The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
Open accessAbstract
IntroductionRheumatoid arthritis (RA) is a chronic, destructive inflammatory polyarticular joint disease, characterized by massive synovial proliferation and subintimal infiltration of inflammatory cells, along with angiogenesis (1, 2).The inflammation of RA results in the production of prostaglandins (PGs) E 2 , cytokines, and nitric oxide (1, 3).In particular, macrophage-derived cytokines such as TNF-α (4) and IL-1 (5), which are abundant in synovial tissues and fluid from patients with RA, are mitogens for synovial fibroblasts, as well as osteoclasts.Blocking of these cytokines inhibits the release of synovial production of other proinflammatory cytokines.This suggests that TNF-α and IL-1 are key proinflammatory molecules in cytokine cascade in RA.In fact, TNF-α receptor antagonists, neutralizing antibodies against TNF-α, and IL-1 receptor antagonist can control joint inflammation in most RA patients (6-8).Moreover, the formation of active inflamed pannus is thought to be critical for erosive disease and results in irreversible destruction of the cartilage and bone in affected joints.The mechanism responsible for synovial hyperplasia leading to pannus formation may be due to reduced apoptosis of inflam-matory cells and tumor-like synoviocytes (9, 10).Therefore, suppression of the production of inflammatory molecules and formation of hyperplastic synovium may be important targets of therapy for RA.Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcriptional factors that include receptors for steroids, thyroid hormone, vitamin D, and retinoic acid (11).PPAR binds to peroxisome proliferator responsive element (PPRE) as a heterodimer with the retinoic receptor (RXR), implying a role of 9-cis retinoic acid in the regulation of PPAR target genes (12, 13).To date, three mammalian PPAR subtypes have been isolated and termed PPAR-α, NUC1 (also known as PPAR-δ), and PPAR-γ (11, 14, 15).PPAR-α is highly expressed in the liver, heart, kidney, muscle, brown adipose tissue, and gut, which exhibit high carbolic rates of fatty acids (14, 16).PPAR-δ may be expressed ubiquitously, and its function is relatively unknown (17).Recent studies suggest that PPAR-δ may be a target for nonsteroidal anti-inflammatory drug-induced (NSAIDinduced) tumor suppression in colorectal tumors (18).PPAR-γ is expressed at high levels in adipose tissue and is a critical regulator of adipocyte differentiation (19).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Elstner, E., Müller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., & Koeffler, H. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8806 · Cited by 805
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., SAID, J. W., Holden, S. A., Miyoshi, I., & Koeffler, H. P. (1998) · PubMed · Cited by 589
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Xin, X., Yang, S., Kowalski, J., & Gerritsen, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9116 · Cited by 513
Angiogenesis: Implications for rheumatoid arthritis
Koch, A. E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<951::aid-art2>3.0.co;2-d · Cited by 504
Schmidt, A. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1634 · Cited by 477
Clark, R. B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., & Padula, S. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1364 · Cited by 465
Self-citationBishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Self-citationEFFECTS OF MANIPULATION OF DIETARY FATTY ACIDS ON CLINICAL MANIFESTATIONS OF RHEUMATOID ARTHRITIS
Kremer, J., Michalek, A., Lininger, L., Huyck, C., Bigauoette, J., Timchalk, M., Rynes, R., Zieminski, J., & Bartholomew, L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92024-0 · Cited by 416
The role of nitric oxide in inflammation and immunity
Clancy, R. M., Amin, A. R., & Abramson, S. B. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1141::aid-art2>3.0.co;2-s · Cited by 409
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor.
Gearing, K. L., Göttlicher, M., Teboul, M., Widmark, E., & Gustafsson, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1440 · Cited by 395
Altiok, S., Xu, M., & Spiegelman, B. M. (1997) · Genes & Development · doi:10.1101/gad.11.15.1987 · Cited by 378
15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway
Straus, D. S. (2000) · Medical Entomology and Zoology · Cited by 371
Sano, H., Hla, T., Maier, J. A., Crofford, L. J., Case, J. P., Maciag, T., & Wilder, R. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115591 · Cited by 345
Self-citationBrock, T. G., McNish, R. W., & Peters-Golden, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11660 · Cited by 304
Kremer, J. M., Lawrence, D. A., Petrillo, G. F., Litts, L. L., Mullaly, P. M., Rynes, R. I., Stocker, R. P., Parhami, N., Greenstein, N. S., Fuchs, B. R., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380813 · Cited by 259
Th1/Th2 cytokine balance in arthritis
Miossec, P., & Berg, W. V. D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401203 · Cited by 257
Campion, G. V., Lebsack, M. E., Lookabaugh, J., & Gordon, G. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390704 · Cited by 247
Serhan, C. N. (1996) · Nature · doi:10.1038/384023a0 · Cited by 234
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
Hopkins, S. J., & Meager, A. (1988) · PubMed · Cited by 187
Biological activities and mechanisms of action of PGJ2 and related compounds: an update
Fukushima, M. (1992) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(92)90178-l · Cited by 186
The biology and pharmacology of PGD2
Giles, H., & Leff, P. (1988) · Prostaglandins · doi:10.1016/0090-6980(88)90093-7 · Cited by 173
Taniguchi, K., Kohsaka, H., Inoue, N., Terada, Y., Ito, H., Hirokawa, K., & Miyasaka, N. (1999) · Nature Medicine · doi:10.1038/10480 · Cited by 168
Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., & Hayaishi, O. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1317 · Cited by 153
Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine.
Hirata, Y., Hayashi, H., Ito, S., Kikawa, Y., Ishibashi, M., Sudo, M., Miyazaki, H., Fukushima, M., Narumiya, S., & Hayaishi, O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37435-0 · Cited by 145
Apoptosis in the rheumatic diseases
Vaishnaw, A. K., McNally, J., & Elkon, K. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401102 · Cited by 98
A Novel Antidiabetic Drug, Troglitazone — Reason for Hope and Concern
Imura, H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381311 · Cited by 57
Synovial Processes in Rheumatoid Arthritis
Fassbender, H. G., & Gay, S. (1988) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748809102945 · Cited by 31
Yamada, R., Sano, H., Hla, T., Hashiramoto, A., Fukui, W., Miyazaki, S., Kohno, M., Tsubouchi, Y., Kusaka, Y., & Kondo, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00707-4 · Cited by 29
Self-citationKikawa, Y., Narumiya, S., & Fukushima, M. (1984) · Cited by 26
Cited by
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Self-citationProstaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Anti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Metadata
- Authors
- Kawahito, Y., Kondo, M., Tsubouchi, Y., Hashiramoto, A., Bishop-Bailey, D., Inoue, K.-I., Kohno, M., Yamada, R., Hla, T., & Sano, H.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-07-15
- Volume
- 106
- Issue
- 2
- Pages
- 189-197
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2124371647
- Cited by
- 377
- References
- 54
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.